- Home
- RSI vs QURE Comparison
RSI vs QURE Comparison
Compare RSI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSI
- QURE
- Stock Information
- Founded
- RSI 2012
- QURE 1998
- Country
- RSI United States
- QURE Netherlands
- Employees
- RSI N/A
- QURE N/A
- Industry
- RSI Services-Misc. Amusement & Recreation
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- RSI Consumer Discretionary
- QURE Health Care
- Exchange
- RSI Nasdaq
- QURE Nasdaq
- Market Cap
- RSI 1.3B
- QURE 725.4M
- IPO Year
- RSI N/A
- QURE 2007
- Fundamental
- Price
- RSI $14.92
- QURE $14.28
- Analyst Decision
- RSI Strong Buy
- QURE Strong Buy
- Analyst Count
- RSI 9
- QURE 10
- Target Price
- RSI $15.88
- QURE $37.20
- AVG Volume (30 Days)
- RSI 1.3M
- QURE 1.2M
- Earning Date
- RSI 07-30-2025
- QURE 07-31-2025
- Dividend Yield
- RSI N/A
- QURE N/A
- EPS Growth
- RSI N/A
- QURE N/A
- EPS
- RSI 0.10
- QURE N/A
- Revenue
- RSI $969,062,000.00
- QURE $20,201,000.00
- Revenue This Year
- RSI $15.68
- QURE N/A
- Revenue Next Year
- RSI $14.13
- QURE $278.91
- P/E Ratio
- RSI $152.61
- QURE N/A
- Revenue Growth
- RSI 29.86
- QURE 6.30
- 52 Week Low
- RSI $8.52
- QURE $3.73
- 52 Week High
- RSI $16.78
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- RSI 72.55
- QURE 47.07
- Support Level
- RSI $14.45
- QURE $13.65
- Resistance Level
- RSI $14.98
- QURE $14.46
- Average True Range (ATR)
- RSI 0.41
- QURE 0.78
- MACD
- RSI 0.05
- QURE -0.18
- Stochastic Oscillator
- RSI 96.63
- QURE 27.21
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.